| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.23 | 2e-06 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |